Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Lumos Diagnostics.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Lumos granted US FDA emergency-use approval for virus test kit, ViraDx
Health & Biotech
ASX Biotech August Winners: Sector down despite CSL and Cochlear’s strong results, but don’t panic…
Health & Biotech
Check Up: Australian biotech sector continues to be a magnet for US investors
Health & Biotech
Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money will go
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: Tech woes and China combine to drag local markets down 1.5pc
News
In Case You Missed It: Lithium leads but health tech is hot on its heels
News
ASX Small Caps Lunch Wrap: What fresh horror from the deep has science delivered today?
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: Local markets close 0.24pc lower, The Star gets a lifeline and Allkem neighbour Rubix flies high
Health & Biotech
ASX Biotech Winners in July: Down but far from out, here’s why biotechs could stage a comeback
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
Lumos CEO on how LDX came back from brink of death to rise 8x, and what to expect next
News
ASX Small Caps Lunch Wrap: Who else is bracing for yet another call for tighter games control?
News
Small Cap Recap and IPO Wrap: Risk suddenly feels awful risky
News
Rise and Shine: Everything you need to know before the ASX opens
News
